[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine]

MeSH terms

• Antipsychotic Agents / administration & dosage
• Antipsychotic Agents / adverse effects*
• Antipsychotic Agents / therapeutic use
• Aripiprazole
• Bromocriptine / therapeutic use*
• Combined Modality Therapy
• Drug Therapy, Combination
• Emergencies
• Frontotemporal Dementia / drug therapy
• Humans
• Imipramine / administration & dosage
• Imipramine / adverse effects*
• Imipramine / therapeutic use
• Lorazepam / administration & dosage
• Lorazepam / analogs & derivatives
• Lorazepam / therapeutic use
• Male
• Mental Disorders / drug therapy
• Middle Aged
• Neuroleptic Malignant Syndrome / diagnosis
• Neuroleptic Malignant Syndrome / drug therapy
• Neuroleptic Malignant Syndrome / etiology*
• Neuroleptic Malignant Syndrome / therapy
• Oxygen Inhalation Therapy
• Piperazines / administration & dosage
• Piperazines / adverse effects*
• Piperazines / therapeutic use
• Quinolones / administration & dosage
• Quinolones / adverse effects*
• Quinolones / therapeutic use
• Respiration, Artificial
• Respiratory Insufficiency / etiology
• Respiratory Insufficiency / therapy